Equity
€1.1m ▲ 18.7%
MEDI - FLOPPY has made a profit in every financial year since 2007.
MEDI - FLOPPY
Lifetime
20 annual accounts with figures on one time axis, 27 filings since 2000peak €403,144 (2026)
€403,144▲ 28.8%
peak €172,176 (2026)
€172,176▲ 49.5%
peak €1.2m (2022)
€1.1m▲ 18.7%
€302,654▼ 16.5%
peak 1 FTE (2018)
-not published
Board1 name since 2022
1 directorLEBON Pierre
Documentsfilings and deeds
15-10-202645 days late
2026micro format
Gross margin from €312,970 to €403,144Result from €115,158 to €172,176Equity from €919,843 to €1.1mDebts from €362,264 to €302,654Cash from €40,513 to €60,265
Key points
from the 2026 annual accountsResult
€172,176 ▲ 49.5%
The result rose in 2026 from €115,158 to €172,176.
Turnover
≈ €600,000 estimated
The micro format states no turnover.
Liquidity
5.15 was 3.68 in 2025
Short-term debts fell from €198,193 to €169,217.
Filings
27 annual accounts since 2000
Nine of the last ten came late. The 2026 accounts came latest: 45 days after the end of the period.
Position in the sector
€1.1m
More equity than 90% of companies in human health. Sector median €185,421 · 496 companies.
Checked score
93
Excellent
Financially stronger than 44% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,192 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%
01-2025: < 0.1%● unchanged vs 12-2024
02-2025: < 0.1%● unchanged vs 01-2025lowest value
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025
08-2025: < 0.1%● unchanged vs 07-2025
09-2025: 0.1%▲ +0.1 percentage points vs 08-2025
10-2025: 0.1%● unchanged vs 09-2025
11-2025: < 0.1%▼ -0.1 percentage points vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: 0.1%▲ +0.1 percentage points vs 05-2026
07-2026: < 0.1%▼ -0.1 percentage points vs 06-2026
08-2026: 0.1%▲ +0.1 percentage points vs 07-2026
09-2026: 0.1%● unchanged vs 08-2026highest value
10-2026: 0.1%● unchanged vs 09-2026
11-2026: 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
raises risk
Last filed accounts filed 45 days late; 2 of the last 3 accounts late
lowers risk
Sector: Human health activities (NACE 86)
Size: total assets €1.7m
Figures for financial year 2026 (filed on 15-10-2026)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 53% of them on solvency, 29% on liquidity, 29% on profitability and 63% on growth.
The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-01-2026.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 20,137 companies had the same profile as MEDI - FLOPPY has now. Each dot stands for 51 companies, two years later.
95.1%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
That fits the bankruptcy probability of MEDI - FLOPPY itself: 0.1% within 12 months.
Test of the method
The method was tested on the 497,448 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 20,137 companies, not a prediction for MEDI - FLOPPY. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €100,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 5.15 (3.68 in 2025), above the usual 1.5. Short-term debt is 10.2% and cash 3.6% of total assets. 34.2% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises risk
lowers risk · Growing equity
Reported equity is higher than in 2024 and did not fall compared with 2025. These amounts do not establish the cause of the change.
NBB · annual accounts 2026Equity per financial year
1920212223242526
2019 to 2026 · latest year €1.1m
raises risk · 2026 accounts filed 45 days late
The financial year that closed on 31-01-2026 was due by 31-08-2026 and was filed on 15-10-2026, 45 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filingsDeviation from the deadline
2026
45 days late
2025
36 days late
2024
24 days late
2023
29 days late
2022
29 days late
2021
30 days late
2020
11 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 29 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-01-2027 and is due by 31-08-2027. Nothing is late today. The company usually files around 29 September (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
11-11-2026 today31-01-2027 year end31-08-2027 deadline
Recent changes
Reappointment: LEBON Pierre (director)
“Direction, organisation et gestion de centres médicaux; Publier et diffuser des articles et ouvrages…” (deed in French) · General meeting of 02-11-2023 · Gazette deed
Incorporation
published on 13-10-1998 · Gazette deed
First establishment
Chemin des Vieux Amis 1, Lasne
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| MEDI - FLOPPY Lasne | €1.7m | €403,144 | 65.8% | - |
| Dr. J.R. SCHOYSMAN Meise | €1.6m | €404,411 | 83.4% | - |
| Dokter VAN MULDERS N., HUISARTS Aalst | €1.9m | €403,716 | 86.3% | - |
| DR. STALS As | €1.7m | €343,990 | 67.9% | - |
| Leenders Viaene Neurologen Geel | €1.5m | €359,985 | 65.4% | - |
| GEORGES VAN HAUWAERT Blankenberge | €1.3m | €424,906 | 89.4% | - |
| DOKTER BAEKELANDT Roeselare | €1.5m | €504,949 | 95.4% | - |
These companies have the same main activity as MEDI - FLOPPY: medical imaging and medical laboratories (NACE 86910). They are comparable in size and age: total assets between €1.3m and €1.9m, founded between 1996 and 2001.
Official details
Source: KBO- Status
- Active since 01-10-1998Normal situation
- Activity
- Medical imaging and medical laboratoriesNACE 86910
- Joint committee
- 330Health institutions and services · annual accounts 31-01-2024
- Establishment unit
- 2.267.147.4451380 Lasne, since 01-10-1998
- Financial year end
- 31 January
- Peppol
- Not found in the Peppol Directory
Insights on MEDI - FLOPPY
MEDI - FLOPPY files the micro format. That format states no turnover. The gross margin rose from €150,615 in 2007 to €403,144 in 2026.
The balance sheet grew most from 2009 to 2011 through fixed assets.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about MEDI - FLOPPY
- What is the company number of MEDI - FLOPPY?
- The company number of MEDI - FLOPPY is 0464.253.282. The VAT number is the same number with BE in front: BE 0464.253.282.
- Where is MEDI - FLOPPY based?
- The registered office is at Chemin des Vieux Amis 1, 1380 Lasne.Company details
- What does MEDI - FLOPPY do?
- According to the KBO register, the main activity is medical imaging and medical laboratories (NACE 86910).
- What is the legal form of MEDI - FLOPPY?
- MEDI - FLOPPY is a private limited company (BV).
- When was MEDI - FLOPPY founded?
- MEDI - FLOPPY was founded on 01-10-1998.
- Is MEDI - FLOPPY still active?
- Yes, MEDI - FLOPPY is an active enterprise in the KBO register.
- How many employees does MEDI - FLOPPY have?
- MEDI - FLOPPY had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does MEDI - FLOPPY fall under?
- In its 31-01-2024 annual accounts, MEDI - FLOPPY states joint committee 330 (Health institutions and services).
- What is the turnover of MEDI - FLOPPY?
- The turnover in financial year 2026 is ≈ €600,000. This figure is estimated from the gross margin of €403,144 and 45 comparable companies (NACE 86). It probably lies between €500,000 and €770,000.
- Is MEDI - FLOPPY profitable?
- In financial year 2026, MEDI - FLOPPY made a profit of €172,176.
- Where can I find the annual accounts of MEDI - FLOPPY?
- MEDI - FLOPPY filed 27 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
- When are the next annual accounts of MEDI - FLOPPY due?
- MEDI - FLOPPY must file the annual accounts for financial year 2027 by 31-08-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.